跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
CANDESARTAN HCTZ AGH 32/25 candesartan cilexetil 32 mg & hydrochlorothiazide 25 mg tablet blister pack
Approved
STANDARD
CANDESARTAN HCTZ AGH 32/25 candesartan cilexetil 32 mg & hydrochlorothiazide 25 mg tablet blister pack
Alembic Pharmaceuticals Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
f4498f27e1d008b5
Company
Alembic Pharmaceuticals Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
f4498f27e1d008b5
Product Name
CANDESARTAN HCTZ AGH 32/25 candesartan cilexetil 32 mg & hydrochlorothiazide 25 mg tablet blister pack
Artg Id
204573
Artg Name
CANDESARTAN HCTZ AGH 32/25 candesartan cilexetil 32 mg & hydrochlorothiazide 25 mg tablet blister pack
Sponsor
Alembic Pharmaceuticals Australia Pty Ltd
Company Detail Path
/organization/alembic-pharmaceuticals-australia-pty-ltd
Artg Date
2013-03-27
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/4801bb54b43d8b3436ff70884e940809.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
f4498f27e1d008b5
Type
Standard
Back to TGA Approvals
CANDESARTAN HCTZ AGH 32/25 candesartan cilexetil 32 mg & hydrochlorothiazide 25 mg tablet blister pack - TGA Drug Approval Details